dalteparin has been researched along with Angiostrongylus Infections in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sandri, ASS | 1 |
| Rodriguez, R | 2 |
| Costa, MM | 1 |
| Porto, SM | 2 |
| Schwingel, D | 1 |
| Vieira, MIB | 1 |
| Dos Santos Ferrari, R | 1 |
| Marcolan, AM | 1 |
| da Silva, AC | 1 |
| Graeff-Teixeira, C | 1 |
| Fornari, F | 1 |
2 other studies available for dalteparin and Angiostrongylus Infections
| Article | Year |
|---|---|
High-dose enoxaparin in the treatment of abdominal angiostrongyliasis in Swiss mice.
Topics: Animals; Anticoagulants; Disease Models, Animal; Enoxaparin; Infarction; Mesenteric Arteries; Mice; | 2018 |
Outcomes in mice with abdominal angiostrongyliasis treated with enoxaparin.
Topics: Angiostrongylus; Animals; Anthelmintics; Chemoprevention; Disease Models, Animal; Enoxaparin; Histoc | 2011 |